Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/9433
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWen, Chia-Hui-
dc.contributor.authorLu, Po-Liang-
dc.contributor.authorLin, Chun-Yu-
dc.contributor.authorLin, Yi-Pei-
dc.contributor.authorChen, Tun-Chieh-
dc.contributor.authorChen, Yen-Hsu-
dc.date.accessioned2024-12-20T03:53:45Z-
dc.date.available2024-12-20T03:53:45Z-
dc.date.issued2023-10-
dc.identifier.citationOriginal Articleen_US
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/9433-
dc.description.abstractbstract Background: People living with HIV (PLWH) are susceptible to non-AIDS-related events, particularly those with immunological nonresponses (INRs) to highly active antiretroviral therapy (HAART). This study assessed the association of INRs with incident non-AIDS-related events among PLWH. stage 3 HIV and received HAART between January 1, 2008, and December 31, 2019. The patients were divided into two groups according to their immunological responses on the 360th day after HAART initiation: INR and non-INR groups. Cox regression and sensitivity analyses were conducted to estimate the effects of INRs on overall and individual categories of nonAIDS-related events (malignancies, vascular diseases, metabolic disorders, renal diseases, and psychiatric disorders). Patient observation started on the 360th day after HAART initiation and continued until February 28, 2022, death, or an outcome of interest, whichever occurred first. Results: Among the 289 included patients, 44 had INRs. Most of the included patients were aged 26e45 years (69.55%) and were men who have sex with men (89.97%). Many patients received HIV diagnoses between 2009 and 2012 (38.54%). INRs (vs. non-INRs) were associated with composite non-AIDS-related events (adjusted hazard ratio [aHR] Z 1.80; 95% confidence interval [CI]: 1.19e2.73) and metabolic disorders (aHR Z 1.75; 95% CI: 1.14e2.68). Sensitivity analyses revealed consistent results for each Cox regression model for both composite nonAIDS-related events and metabolic diseases. Conclusion: Clinicians should be vigilant and implement early intervention and rigorous monitoring for non-AIDS-related events in PLWH with INRs to HAART.en_US
dc.language.isoen_USen_US
dc.publisherElsevier Taiwan LLCen_US
dc.subjectAIDSen_US
dc.subjectHIVen_US
dc.subjectImmunological non-responseen_US
dc.titleEffect of immunological non-response on incidence of Non-AIDS events in people living with HIV: A retrospective multicenter cohort study in Taiwanen_US
dc.typeArticleen_US
Appears in Collections:VOL 56 NO 5 2023

Files in This Item:
File Description SizeFormat 
977-987.pdf895.38 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.